Reimbursement Decisions Logo
Guest | Login/Register
Your foremost guide to global pricing and reimbursement decisions.TM

CDR Reimbursement Decisions Database

Update frequency: Weekly
Last updated: Nov 09 2016

The searchable, online version of the CDR Decisions database contains all recommendations from establishment of CDR and is updated regularly. The CDR Decisions database is currently available without registration for the year 2011. For full access to the CDR database, please register. For custom analyses, please contact us.

Filter your results:
Brand Name: Generic Drug Name:
Manufacturer: Body System/Condition:
Indication: Recommendation Summary:
Year:  

Records 1 to 28 of 28
Brand Name Generic Name Manufacturer Body System/Condition Indication Recommend-
ation Summary
Date Recommend-
ation Issued
Abilify  aripiprazole  Bristol-Myers Squibb Canada  Mental and behavioural disorders   schizophrenia, schizoaffective  List with criteria/condition  2011-07-18 
Abstral  Fentanyl citrate  Paladin Labs Inc.  Nervous system   pain  Do not list  2011-12-16 
Aclasta  Zoledronic acid  Novartis Pharmaceuticals Canada Inc.  Musculoskeletal   osteoporosis  List with criteria/condition  2011-11-16 
Brilinta  Ticagrelor  AstraZeneca Canada Inc.  Cardiovascular   acute coronary syndrome  Do not list  2011-12-16 
BuTrans  buprenorphine transdermal patch  Purdue Pharma  Nervous system   pain  Do not list  2011-09-28 
Cayston  Aztreonam for inhalation solution  Gilead Sciences Canada Inc.  Endocrine, nutritional and metabolic diseases   cystic fibrosis  List with criteria/condition  2011-07-18 
Celsentri  Maraviroc  ViiV Healthcare ULC  Infectious and parasitic diseases   HIV  Do not list  2011-07-18 
Daxas  roflumilast  Nycomed Canada Inc.  Respiratory   COPD  Do not list  2011-07-27 
Effient  Prasugrel hydrochloride  Eli Lilly Canada Inc.  Cardiovascular   acute coronary syndrome  Do not list  2011-02-16 
Finacea  Azelaic acid  Bayer Inc.  Skin and subcutaneous tissue   rosacea  List  2011-02-16 
Gilenya  Fingolimod  Novartis Pharmaceuticals Canada Inc.  Nervous system   multiple sclerosis  List with criteria/condition  2011-11-16 
Ilaris  Canakinumab  Novartis Pharmaceuticals Canada Inc.  Endocrine, nutritional and metabolic diseases   Cryopyrin-Associated Periodic Syndromes (CAPS)  Do not list  2011-01-26 
Invega Sustenna  Paliperidone palmitate  Janssen-Ortho Inc.  Mental and behavioural disorders   schizophrenia  Do not list  2011-04-25 
Kuvan  sapropterin dihydrochloride  BioMarin Pharmaceutical (Canada) Inc.  Endocrine, nutritional and metabolic diseases   PKU  Do not list  2011-01-26 
Nucynta CR  tapentadol  Janssen Inc.  Nervous system   pain  Do not list  2011-09-28 
Pradaxa  dabigatran etexilate  Boehringer Ingelheim (Canada) Ltd.  Cardiovascular   atrial fibrilation  List with criteria/condition  2011-06-22 
Prolia  Denosumab  Amgen Canada Inc.  Musculoskeletal   osteoporosis  List with criteria/condition  2011-03-30 
Restasis ophthalmic emulsion  Cyclosporine  Allergan Inc.  Eye  dry eye disease  Do not list  2011-07-18 
Revolade  eltrombopag olamine  GlaxoSmithKline Inc.  Immune System   chronic ITP  Do not list  2011-10-24 
Toctino  Alitretinoin  Actelion  Skin and subcutaneous tissue   eczema  List with criteria/condition  2011-10-24 
Twynsta  Telmisartan / Amlodipine  Boehringer Ingelheim (Canada) Ltd.  Cardiovascular   hypertension  List  2011-12-16 
Uloric  febuxostat  Takeda Canada Inc.  Endocrine, nutritional and metabolic diseases   gout  List with criteria/condition  2011-04-25 
Victoza  liraglutide  Novo Nordisk Canada Inc.  Endocrine, nutritional and metabolic diseases   diabetes  Do not list  2011-09-28 
Victrelis  Boceprevir  Merck Canada Inc.  Infectious and parasitic diseases   hepatitis C  List with criteria/condition  2011-10-24 
Vimpat  lacosamide  UCB Canada Inc.  Nervous system   epilepsy  List with criteria/condition  2011-04-25 
VPRIV  velaglucerase alfa  Shire Human Genetic Therapies  Endocrine, nutritional and metabolic diseases   Gaucher disease  List with criteria/condition  2011-04-25 
XGEVA  denosumab  Amgen Canada Inc.  Musculoskeletal   prostate cancer  List with criteria/condition  2011-11-16 
Zenhale (inhalation aerosol)  Mometasone furoate / formoterol fumarate   Merck Canada Inc.  Respiratory   asthma  Do not list  2011-09-28 

Records 1 to 28 of 28

Return to Top